CYTEK BIOSCIENCES, INC. Increase Decrease In Operating Lease Liability
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase Decrease In Operating Lease Liability of $1.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $2.08M.
- CYTEK BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$159.00K.
- CYTEK BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.08M.
- CYTEK BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$1.16M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month |
|---|---|---|---|
| 2026-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.92M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$159.00K 10-Q · filed 2026-05-07 | ||
| 2025-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.24M derived: sum of 2 quarters · filed 2026-08-05 | -$3.28M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.20M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | -$1.03M 10-Q · filed 2026-05-07 | ||
| 2024-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.57M derived: sum of 2 quarters · filed 2025-11-05 | -$2.30M 10-Q · filed 2025-11-05 |
| 2024-06-30 | -$433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.16M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | -$727.00K 10-Q · filed 2025-05-08 | ||
| 2023-09-30 | -$739.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.45M derived: sum of 2 quarters · filed 2024-11-07 | -$2.15M 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.42M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | -$706.00K 10-Q · filed 2024-05-08 | ||
| 2022-09-30 | -$1.41M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |